Abstract book 6th RMS 16.indd

etter way to determine risk and to follow
thus complication.
181
Comparison of the Versa TREK Blood
Culture System Against The BACTEC
MGIT 960 and Conventional Culture
Method for the Detection of M.
Tuberculosis
Ibrahim Jbara MSc*, Salem Ziad BSc, Maiy
ZOUBI BSc, Ismail Al-Shawabke MSc , Haifa
Khashashneh BSc,Linda Al-Qaoud, BSc
* Princess Iman Research & Laboratory Sciences
Center Royal Medical Services (Jordan)
ibrahimjbara@yahoo.com
Objectives: The aim of this study was
to evaluate the reliability of Versa TREK
system for detection of M. tuberculosis
compared with results obtained with
Bactec MGIT 960 system and Löwenstein
– Jensen medium
Methods: A total of 50 different clinical
specimens ( 25 Bronchial wash, 19 sputum,
3 pleural fluid, 1 CSF, 1 pericardial effusion
and 1 ascitic fluid ) from patients with
suspected tuberculosis were evaluated
with two known positive samples control
over two months ( Oct. – Nov. 2011 ) at
King Hussein Medical Center. Clinical
specimens were processed using the
standard N-acetyl-L-cysteine (NALC)-NaOH
method, then inoculated onto Versa TREK
system, BACTEC MGIT 960 and Löwenstein
– Jensen slants at the same time.
Results: Of 50 specimens cultured, a total
of 1 positive specimen for mycobacterial
isolated after 6 days from inoculation onto
both Versa TREK system and BACTEC MGIT
960, and after 10 days on Löwenstein –
Jensen slants, with smear – negative , in
addition to two positive sample control.
Overall, mycobacterial positivity rates were
equivalent 2% for all cultural methods
applied excluding the two positive sample
control.
Conclusion: The Versa TREK system
is validated for the detection of M.
tuberculosis, and was equivalent to
BACTEC MGIT 960 when accessing total
mycobacteria positivity rates for specimens
submitted from patients with suspected
tuberculosis . Detection and recovery rates
for all of these broth - culture systems
are comparable to each other despite the
principle of their technique and superior to
those of conventional solid media
182
IS/IT Strategy for the Queen Rania
Al-Abdullah Hospital for Children
Omar I Ayesh, Biomedical Engineering, Senior
BioMedical Engineer at The Private Medical
Office, The Royal Hashemite Court. Member of
the national E-health committee. Jordan
oayesh@rhc.jo
Objectives: QRHC is managed, operated
and financed by the RMS. IS/IT strategy
sets a clear guide and steps need to be
taken and address current weakness and
opportunities to reach. One major step
towards enhancing healthcare services
is operational improvements with the
objective of optimizing efficiency and
containing costs, while improving quality
of services. IT is seen as a key enabler to
improve healthcare processes due to its
potential of providing rapid access to
information at the point-of-care.
Methods: This works is based on strategic
analysis of existing systems, the review
of academic literature and the 21 years
personal experience of the author at RMS.
It will focus on the E-health strategy as part
the national E-Health program (Hakeem)
that is planned to cover all Public hospitals
and clinics.
Results: IS/IT strategy is intended to
provide QRHC with the IS/ IT systems
that allow business benefits that is safe,
efficient, effective, timely, evidence based,
patient centered and equitable to all
patients
Conclusion: This IS/IT strategy is intended
to provide QRHC with the professional
IT systems that allow business benefits
that are safe, efficient, effective, timely,
evidence based, patient centered and
equitable to all patients. To justify the
support of the decision makers IS/IT should
be looked at as strategic business units.
The alignment of IS in support of the
organizational objectives and strategies
has been among the top concerns, failure
to can result in lost opportunities, wasted
resources and consequent unfavorable
performance.
www.jrms.gov.jo
104